Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 3
1995 1
1996 1
1997 1
1999 2
2000 1
2001 1
2002 1
2003 2
2004 4
2005 9
2006 19
2007 19
2008 15
2009 14
2010 7
2011 4
2012 2
2013 4
2014 6
2015 7
2016 6
2017 9
2018 1
2019 5
2020 3
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

135 results
Results by year
Filters applied: . Clear all
Page 1
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.
Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Müller-Hermelink HK, Campo E, Braziel RM, Jaffe ES, Pan Z, Farinha P, Smith LM, Falini B, Banham AH, Rosenwald A, Staudt LM, Connors JM, Armitage JO, Chan WC. Hans CP, et al. Among authors: banham ah. Blood. 2004 Jan 1;103(1):275-82. doi: 10.1182/blood-2003-05-1545. Epub 2003 Sep 22. Blood. 2004. PMID: 14504078 Free article.
Therapeutic Antibodies against Intracellular Tumor Antigens.
Trenevska I, Li D, Banham AH. Trenevska I, et al. Among authors: banham ah. Front Immunol. 2017 Aug 18;8:1001. doi: 10.3389/fimmu.2017.01001. eCollection 2017. Front Immunol. 2017. PMID: 28868054 Free PMC article. Review.
The oncogenic roles of TRPM ion channels in cancer.
Wong KK, Banham AH, Yaacob NS, Nur Husna SM. Wong KK, et al. Among authors: banham ah. J Cell Physiol. 2019 Feb 2. doi: 10.1002/jcp.28168. Online ahead of print. J Cell Physiol. 2019. PMID: 30710353 Review.
A review of ELTD1, a pro-angiogenic adhesion GPCR.
Favara DM, Banham AH, Harris AL. Favara DM, et al. Among authors: banham ah. Biochem Soc Trans. 2014 Dec;42(6):1658-64. doi: 10.1042/BST20140216. Biochem Soc Trans. 2014. PMID: 25399586 Review.
The significance of FOXP1 in diffuse large B-cell lymphoma.
Gascoyne DM, Banham AH. Gascoyne DM, et al. Among authors: banham ah. Leuk Lymphoma. 2017 May;58(5):1037-1051. doi: 10.1080/10428194.2016.1228932. Epub 2016 Sep 27. Leuk Lymphoma. 2017. PMID: 27678023 Review.
The notch ligand JAGGED1 as a target for anti-tumor therapy.
Li D, Masiero M, Banham AH, Harris AL. Li D, et al. Among authors: banham ah. Front Oncol. 2014 Sep 25;4:254. doi: 10.3389/fonc.2014.00254. eCollection 2014. Front Oncol. 2014. PMID: 25309874 Free PMC article. Review.
FOXP1: a potential therapeutic target in cancer.
Koon HB, Ippolito GC, Banham AH, Tucker PW. Koon HB, et al. Among authors: banham ah. Expert Opin Ther Targets. 2007 Jul;11(7):955-65. doi: 10.1517/14728222.11.7.955. Expert Opin Ther Targets. 2007. PMID: 17614763 Free PMC article. Review.
Development of Therapeutic Anti-JAGGED1 Antibodies for Cancer Therapy.
Masiero M, Li D, Whiteman P, Bentley C, Greig J, Hassanali T, Watts S, Stribbling S, Yates J, Bealing E, Li JL, Chillakuri C, Sheppard D, Serres S, Sarmiento-Soto M, Larkin J, Sibson NR, Handford PA, Harris AL, Banham AH. Masiero M, et al. Among authors: banham ah. Mol Cancer Ther. 2019 Nov;18(11):2030-2042. doi: 10.1158/1535-7163.MCT-18-1176. Epub 2019 Aug 8. Mol Cancer Ther. 2019. PMID: 31395687 Free PMC article.
135 results